Clinical Trial Details
— Status: Enrolling by invitation
Administrative data
NCT number |
NCT05010473 |
Other study ID # |
STU00219433 |
Secondary ID |
R01DC013315 |
Status |
Enrolling by invitation |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
January 20, 2022 |
Est. completion date |
January 20, 2026 |
Study information
Verified date |
May 2024 |
Source |
Northwestern University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The frequency-following response (FFR), a scalp-recorded neurophonic potential, is a widely
used metric of speech encoding integrity in healthy and clinical human populations. The
translational potential of the FFR as a biomarker is constrained by poor understanding of its
neural generators and influencing factors. This study leverages a cross-species and
cross-level approach to provide mechanistic insight into the properties of the cortical
source of the FFR, and elucidate the role of cortical feedback via cortico-collicular
projections on modulation of the FFR as a function of stimulus context, arousal state, and
category relevance. This clinical trial will focus on the influences of category relevance,
predictability, and participant arousal state on the FFRs in neurotypical human participants.
Description:
Participants will listen to a variety of sounds while the frequency-following response (FFR)
is recorded. The FFR is a sound-evoked response that mirrors the acoustic properties of the
incoming acoustic signal with remarkable fidelity. The FFR is now recognized as an integrated
response resulting from an interplay of early auditory subcortical and cortical systems. The
cortical dynamics underlying the FFR are unclear. All stimuli will be normalized to the same
root mean squared amplitude and stimulus duration and played at the same in-the-ear
intensity. Thirty-two stimuli from human and animal natural productions with a wide-range of
F0 will be used to elicit the FFR. At least 1000 artifact-free trials will be collected for
every stimulus. Participants will sit in a quiet room (patients) or a sound-treated booth and
listen to sounds while electroencephalography (EEG) and pupillometry signals are continuously
acquired. EEG signals will be collected using Ag-AgCl scalp electrodes, with the active
electrode placed at the central zero (Cz) point, the reference at the right mastoid, and the
ground at the left mastoid. Contact impedence will be< 5 kΩ for all electrodes for all
recording sessions, and responses will be recorded at a sampling rate of 25 kHz using Brain
Vision PyCorder 1.0.7 (Brain Products, Gilching, Germany). Alternating polarities of the
stimuli will be binaurally presented in sound field (identical to the animal protocols), with
an inter-stimulus interval jittered between 122 to 148ms. Participants will be instructed to
stay awake and refrain from making extraneous movements. EEG and pupil measures will allow
continuous monitoring of participant state. The order of blocks will be counterbalanced
across participants, and stimulus presentation will be controlled by E-Prime 2.0.10 software.
The electrophysiological data will be preprocessed with BrainVision Analyzer 2.0 (Brain
Products, Gilching, Germany), bandpass filtered (varies based on stimulus F0; 12 dB/octave,
zero phase-shift). The bandpass filter will approximately reflect the lower and upper limits
of phase-locking along the auditory pathway that contributes to the FFR (auditory cortex,
midbrain). Responses will be segmented into epochs, baseline corrected to the mean voltage of
the noise floor(-40 to 0ms). Epochs in which the amplitude exceeds ± 35μV will be considered
artifacts and rejected. In each session, a preset number of artifact-free FFR trials (500 for
each polarity) will be obtained. For pupillometry, participants will be seated in a chair and
will place their head on a chin rest. The stabilized mount also has a small horizontal bar
that they can place their forehead against. To calibrate the eye tracker, participants will
be asked to follow 9 dots that appear on a monitor with their eyes. Insert earbuds will be
placed in both ears, and auditory stimuli will be presented binaurally. Pupillometry data
will be preprocessed to remove noise from the analysis. The pupil data will be downsampled to
50 Hz. Trials with more than 15% of the samples detected as blinks will be removed. Missing
samples due to blinks will be linearly interpolated from approximately100 ms prior to and 100
ms after the blink. Pupil responses will be baseline normalized using the average pupil size
in the 500-1000 ms prior to the onset of the auditory stimuli. A key variable reported will
be the percent change in pupil size.